Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782923 · ClinicalTrials.gov registry record · NA
Driving After Cervical Spine Surgery
A NA study of Cervical Disc Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT02782923: Completed NA study of Cervical Disc Disease, sponsored by NYU Langone Health.
NCT02782923 is a NA study of Cervical Disc Disease that has completed, run by NYU Langone Health. The registered enrollment target is 19 participants, below the 216-participant average among 3 other Cervical Disc Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02782923, a NA study of Cervical Disc Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, prospective controlled simulation study designed comparing and evaluating the driving performance of subjects who have had cervical spine surgery and the use of a validated driving simulator. To date, there haven't been evidence-based recommendations to determine a patient's "fitness to drive" in the peri-operative or postoperative state. The objective of this study is to delineate the effect cervical spine procedures have on driving performance in the peri-operative time period. The study will take place at New York University Langone Medical Center - Hospital for Joint Diseases which will include the surgeries. The follow up visits will be at the NYU Center for Musculoskeletal Care.
Primary Outcome
Change from Baseline in Overall collisions (BL-3mo). Includes both "off-road" and "on-road" collisions.
Conditions Studied
Interventions
- DEVICE STISIM driving simulator
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-07-17 |
| Phase | NA |
What the finished NCT02782923 record still lists
NCT02782923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 216-participant average among 3 other Cervical Disc Disease trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cervical Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which STISIM driving simulator is the first listed.
NCT02782923 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02782923 about?
NCT02782923 is a clinical study titled "Driving After Cervical Spine Surgery". This is a single-center, prospective controlled simulation study designed comparing and evaluating the driving performance of subjects who have had cervical spine surgery and the use of a validated driving simulator. To date, there haven't been evidence-based recommendations to determine a patient's...
What is the current status of trial NCT02782923?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-12. Estimated completion is 2018-07-17.
What conditions does trial NCT02782923 study?
This clinical trial studies the following conditions: Cervical Disc Disease.
What interventions are being tested in trial NCT02782923?
The interventions under investigation include: STISIM driving simulator (DEVICE).
Who is sponsoring clinical trial NCT02782923?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02782923 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Cervical Disc Disease at 2 Contiguous Levels
ACTIVE NOT RECRUITING · NA
-
Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc
ACTIVE NOT RECRUITING
-
Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia